Skip to main content

Advertisement

SpringerLink
Log in

Successful twin pregnancy while on cyclophosphamide therapy in a patient with lupus nephritis

  • Case Report
  • Published:
Rheumatology International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Steinberg AD, Steinberg SC (1991) Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only. Arthritis Rheum 34:945–950. doi:10.1002/art.1780340803

    Article  PubMed  CAS  Google Scholar 

  2. Wang CL, Wang F, Bosco JJ (1995) Ovarian failure in oral cyclophosphamide treatment for systemic lupus erythematosus. Lupus 4:11–14. doi:10.1177/096120339500400103

    Article  PubMed  CAS  Google Scholar 

  3. Boumpas DT, Austin HA, Vaughan EM et al (1993) Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy. Ann Intern Med 119:366–369

    PubMed  CAS  Google Scholar 

  4. Enns GM, Roeder E, Chan RT et al (1999) Apparent cyclophosphamide (Cytoxan) embryopathy: a distinct phenotype? Am J Med Genet 86:237–241. doi:10.1002/(SICI)1096-8628(19990917)86:3<237::AID-AJMG8>3.0.CO;2-V

    Article  PubMed  CAS  Google Scholar 

  5. Koren G, Pastuszak A, Ito S (1998) Drugs in pregnancy. N Engl J Med 338:1128–1137. doi:10.1056/NEJM199804163381607

    Article  PubMed  CAS  Google Scholar 

  6. Austin HA, Klippel JH, Balow JE et al (1986) Therapy of lupus nephritis: controlled trial of prednisone and cytotoxic drugs. N Engl J Med 314:614–619

    PubMed  Google Scholar 

  7. Park MC, Park YB, Jung SY et al (2004) Risk of ovarian failure and pregnancy outcome in patients with lupus nephritis treated with intravenous cyclophosphamide pulse therapy. Lupus 13:569–574. doi:10.1191/0961203304lu1063oa

    Article  PubMed  CAS  Google Scholar 

  8. Huong DL, Amoura Z, Duhaut P et al (2002) Risk of ovarian failure and fertility after intravenous cyclophosphamide. A study in 84 patients. J Rheumatol 9:2571–2576

    Google Scholar 

  9. Medeiros MM, Silveira VA, Menezes AP et al (2001) Risk factors for ovarian failure in patients with systemic lupus erythematosus. Braz J Med Biol Res 34:1561–1568. doi:10.1590/S0100-879X2001001200008

    Article  PubMed  CAS  Google Scholar 

  10. Mok CC, Lau CS, Wong RW (1998) Risk factors for ovarian failure in patients with systemic lupus erythematosus receiving cyclophosphamide therapy. Arthritis Rheum 41:831–837. doi:10.1002/1529-0131(199806)41:6<1090::AID-ART16>3.0.CO;2-6

    Article  PubMed  CAS  Google Scholar 

  11. Katsifis GE, Tzioufas AG (2004) Ovarian failure in systemic lupus erythematosus patients treated with pulsed intravenous cyclophosphamide. Lupus 13:673–678. doi:10.1191/0961203304lu2012oa

    Article  PubMed  CAS  Google Scholar 

  12. Matsukawa Y, Nishinarita S, Horie T et al (1998) Successful child bearing during intravenous cyclophosphamide therapy in a patient with systemic lupus erythematosus. Br J Rheumatol 37:342–343. doi:10.1093/rheumatology/37.3.342

    Article  PubMed  CAS  Google Scholar 

  13. Kart Koseoglu H, Yucel AE, Kunefeci G et al (2001) Cyclophosphamide therapy in a serious case of lupus nephritis during pregnancy. Lupus 10:818–820. doi:10.1177/096120330101001110

    Article  PubMed  CAS  Google Scholar 

  14. Clowse ME, Magder L, Petri M (2005) Cyclophosphamide for lupus during pregnancy. Lupus 14:593–597. doi:10.1191/0961203305lu2169oa

    Article  PubMed  CAS  Google Scholar 

  15. Zemlickis D, Lishner M, Erlich R et al (1993) Teratogenicity and carcinogenicity in a twin exposed in utero to cyclophosphamide. Teratog Carcinog Mutagen 13:139–143. doi:10.1002/tcm.1770130304

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Immunology and Rheumatology Services, All India Institute of Medical Sciences, New Delhi, India

    Rajiva Gupta

  2. Department of Medicine, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029, India

    Rajiva Gupta, S. Deepanjali, M. M. Thabah & P. Kaur

  3. Department of Oral Medicine and Radiology, Maulana Azad Institute of Dental Sciences, New Delhi, India

    S. Gupta

Authors
  1. Rajiva Gupta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Deepanjali
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. M. Thabah
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. Kaur
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. Gupta
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rajiva Gupta.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gupta, R., Deepanjali, S., Thabah, M.M. et al. Successful twin pregnancy while on cyclophosphamide therapy in a patient with lupus nephritis. Rheumatol Int 29, 1503–1505 (2009). https://doi.org/10.1007/s00296-009-0860-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-009-0860-4

Keywords

Search

Navigation